safusidenib
safusidenib: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Nuvation Bio Inc. (NUVB) | Phase 3 |
FDA Decisions
FDA_MeetingThe FDA agreed that PFS assessed by Blinded Independent Central Review per RANO 2.0 could support full approval for maintenance treatment of high-grade IDH1‑mutant gliomas.(NUVB)
Frequently asked questions
Who is developing safusidenib?
safusidenib is being developed by Nuvation Bio Inc..
What is safusidenib's latest FDA decision?
The most recent tracked FDA decision for safusidenib is FDA_Meeting for The FDA agreed that PFS assessed by Blinded Independent Central Review per RANO 2.0 could support full approval for maintenance treatment of high-grade IDH1‑mutant gliomas..
Get deeper analysis on safusidenib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis